Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anke L. W. Huckriede"'
Autor:
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, Laura L. A. van Dijk, Lennert Gommers, Leanne P. M. van Leeuwen, Sharona Rugebregt, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Virgil A. S. H. Dalm, Melvin Lafeber, Neeltje A. Kootstra, Anke L. W. Huckriede, Bart L. Haagmans, Debbie van Baarle, Marion P. G. Koopmans, SWITCH-ON Research Group, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, bivalent mRNA-based booster vaccines encoding the ancestral spike p
Externí odkaz:
https://doaj.org/article/7b4e0251847c419a88ac331e321a07cb
Autor:
Ngoc H. Tan, Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Susanne Bogers, Daryl Geers, Luca M. Zaeck, Marion P. G. Koopmans, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke L. W. Huckriede, Debbie van Baarle, Melvin Lafeber, Corine H. GeurtsvanKessel, Rory D. de Vries, Paul-Hugo Marie van der Kuy
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccination against coronavirus disease 2019 (COVID-19) has contributed greatly to providing protection against severe disease, thereby reducing hospital admissions and deaths. Several studies have reported reduction in vaccine effectiveness over tim
Externí odkaz:
https://doaj.org/article/1358e918a21143969773cb64ea909552
Autor:
Rick Heida, Paul Hagedoorn, Melle C. van Meel, Jurrie E. R. Prins, Frederike S. Simonis, Renate Akkerman, Anke L. W. Huckriede, Henderik W. Frijlink, Anne H. de Boer, Wouter L. J. Hinrichs
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1847 (2023)
A challenge in the development of dry powder formulations for inhalation is the poor reproducibility of their administration to small laboratory animals. The currently used devices for the pulmonary administration of dry powder formulations to small
Externí odkaz:
https://doaj.org/article/c2bc6f0880c242f2a92f0fd9c3281db0
Autor:
Renée S. van der Kooij, Martin Beukema, Anke L. W. Huckriede, Johan Zuidema, Rob Steendam, Henderik W. Frijlink, Wouter L. J. Hinrichs
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 676 (2023)
Although vaccination is still considered to be the cornerstone of public health care, the increase in vaccination coverage has stagnated for many diseases. Most of these vaccines require two or three doses to be administered across several months or
Externí odkaz:
https://doaj.org/article/27a8c796e4d9408694c042d4ad83969b
Autor:
Adriana Tami, Bernardina T. F. van der Gun, Karin I. Wold, María F. Vincenti-González, Alida C. M. Veloo, Marjolein Knoester, Valerie P. R. Harmsma, Gerolf C. de Boer, Anke L. W. Huckriede, Daniele Pantano, Lilli Gard, Izabela A. Rodenhuis-Zybert, Vinit Upasani, Jolanda Smit, Akkelies E. Dijkstra, Jacco J. de Haan, Jip M. van Elst, Jossy van den Boogaard, Shennae O’ Boyle, Luis Nacul, Hubert G. M. Niesters, Alex W. Friedrich
Publikováno v:
PLoS ONE, Vol 17, Iss 11 (2022)
Background Guidelines on COVID-19 management are developed as we learn from this pandemic. However, most research has been done on hospitalised patients and the impact of the disease on non-hospitalised and their role in transmission are not yet well
Externí odkaz:
https://doaj.org/article/539be222ea39407e89bea4f3560a60b1
Autor:
Roos S. G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L. W. Huckriede, Marion P. G. Koopmans, Melvin Lafeber, Douwe F. Postma, Debbie van Baarle, Leo G. Visser, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Wim J. R. Rietdijk, P. Hugo M. van der Kuy
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/21c54a720c2448ea8a74e527222a33ae
Autor:
Valentina Vignali, Tobi Hoff, Jacqueline J. de Vries-Idema, Anke L. W. Huckriede, Jan Maarten van Dijl, Patrick van Rijn
Publikováno v:
Applied Sciences, Vol 12, Iss 14, p 7239 (2022)
Hygiene is a basic necessity to prevent infections, and though it is regarded as vital in general, its importance has been stressed again during the pandemic. Microbes may spread through touch and aerosols and thereby find their way from host to host
Externí odkaz:
https://doaj.org/article/d74ca1e072f74fc8aea8e3b7a8630c20
Autor:
Rick Heida, Philip A. Born, Gabriela Tapia-Calle, Henderik W. Frijlink, Anna Salvati, Anke L. W. Huckriede, Wouter L. J. Hinrichs
Publikováno v:
Pharmaceuticals, Vol 15, Iss 7, p 887 (2022)
Viral subunit vaccines are a safer and more tolerable alternative to whole inactivated virus vaccines. However, they often come with limited efficacy, necessitating the use of adjuvants. Using free and particle-bound viral antigens, we assessed wheth
Externí odkaz:
https://doaj.org/article/b80fc80388764e589a795e4b84336c84
Autor:
Yu Tian, Yoshita C. Bhide, Herman J. Woerdenbag, Anke L. W. Huckriede, Henderik W. Frijlink, Wouter L. J. Hinrichs, J. Carolina Visser
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 245 (2020)
Most influenza vaccines are administered via injection, which is considered as user-unfriendly. Vaccination via oral cavity using an orodispersible film (ODF) might be a promising alternative. To maintain the antigenicity of the vaccine during prepar
Externí odkaz:
https://doaj.org/article/b94fa34e37d440888e89748f0e0fe569
Autor:
Hinrichs, Rick Heida, Paul Hagedoorn, Melle C. van Meel, Jurrie E. R. Prins, Frederike S. Simonis, Renate Akkerman, Anke L. W. Huckriede, Henderik W. Frijlink, Anne H. de Boer, Wouter L. J.
Publikováno v:
Pharmaceutics; Volume 15; Issue 7; Pages: 1847
A challenge in the development of dry powder formulations for inhalation is the poor reproducibility of their administration to small laboratory animals. The currently used devices for the pulmonary administration of dry powder formulations to small